03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Nyolol Ophthalmic Gel* : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | Khalil Fattal & Fils |
Distributor | Khalil Fattal & Fils |
Laboratory | Novartis |
Responsible Party | Novartis Pharma AG |
Origin | Switzerland |
Manufacturer | Excelvision AG |
Origin | Switzerland |
ATC | S01ED01 |
Revision Date | 01/12/2004 |
Nyolol Ophthalmic Gel* :
Nyolol Ophthalmic Gel* :
Nyolol Ophthalmic Gel* :
Nyolol Ophthalmic Gel* :
Nyolol Ophthalmic Gel* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Nyolol Ophthalmic Gel* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Allergic reaction | Not known |
Alopecia | Not known |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Not known |
Application site burn | Not known |
Arrhythmia | Rare |
Arthropathy | Not known |
Asthenia | Not known |
Atrioventricular block (AVB) | Rare |
Atrioventricular block complete | Rare |
Blepharitis | Rare |
Bradycardia | Not known |
Bronchospasm | Rare |
Cardiac arrest | Rare |
Cephalea | Not known |
Cerebral ischaemia | Rare |
Cerebrovascular accident | Rare |
Chest pain | Not known |
Congestive heart failure | Rare |
Conjunctivitis | Not known |
Depression | Not known |
Diarrhoea (Diarrhea) | Not known |
Diplopia | Not known |
Dizziness | Not known |
Dry eye | Not known |
Dyspnoea (dyspnea) | Not known |
Exanthema | Not known |
Eye irritation | Not known |
Eyes stinging (Ocular stinging) | Not known |
Fatigue | Not known |
Foreign body sensation in eyes | Not known |
Hypoesthesia eye | Rare |
Hypoglycaemia | Not known |
Hypotension | Rare |
Keratitis | Not known |
Myasthenia gravis aggravated | Not known |
Nausea | Not known |
Palpitations | Rare |
Ptosis | Rare |
Respiratory failure | Rare |
Retinal detachment | Not known |
Syncope | Not known |
Urticaria | Not known |
Vision blurred | Not known |
Vomiting | Not known |
Nyolol Ophthalmic Gel* :
NB : Products With Same Indication |
Different Units By MoH Code
Nyolol Ophthalmic Gel* MoH 2048 :
Form | Eye Gel |
Packaging | Tube |
Package Size | 1x5g |
Strength | 0.1% |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 405651/00 |
Submission date | 01/01/2000 |
Registration Year | 2000 |
Archived Date | 2019 |
Price Comparison
● Country: | Oman | |
● Package Size: | 5g | |
● Public Price: | 2.48 OMR | ( 572,220.32 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 0,0827 OMR | ( 0.00 LBP ) |
● Pricing Date: | 19/02/2021 | |
● Type: | Medicine Authorised |
● Country: | Switzerland | |
● Package Size: | 5g | |
● Public Price: | 8.45 CHF | ( 873,899.00 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 0,2817 CHF | ( 0.00 LBP ) |
● Exfactory Price: | 3.791242 CHF | |
● Pricing Date: | 01/09/2017 | |
● Type: | Medicine Non Marketed |
● Country: | Qatar | |
● Package Size: | 5g | |
● Public Price: | 24 QAR | ( 589,392.00 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 0,8 QAR | ( 0.00 LBP ) |
● Pharmacy Price: | 19.354659896 QAR | ( 475311.73772597 LBP ) |
● Pricing Date: | 28/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Abu Dhabi | |
● Package Size: | 5g | |
● Public Price: | 27.5 AED | ( 664,427.50 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 0,9167 AED | ( 0.00 LBP ) |
● Pharmacy Price: | 22.49 AED | ( 543380.89 LBP ) |
● Pricing Date: | 27/01/2021 | |
● Type: | Medicine Authorised |
● Country: | UAE | |
● Package Size: | 5g Dropper Bottle | |
● Public Price: | 27.5 AED | ( 664,427.50 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 0,9167 AED | ( 0.00 LBP ) |
● Pharmacy Price: | 22.49 AED | ( 543380.89 LBP ) |
● Pricing Date: | 21/08/2019 | |
● Type: | Medicine Authorised |
● Country: | KSA | |
● Package Size: | 1x5g | |
● Public Price: | 23 SAR | ( 543,720.00 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 0,7667 SAR | ( 0.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 05/03/2020 | |
● Type: | Medicine Non Marketed |
You have to register to view this info
Drop File